Ignite Creation Date:
2024-05-05 @ 5:05 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00380133
Status:
COMPLETED
Last Update Posted:
2012-06-04
First Post:
2006-09-21
Brief Title:
Study of SB681323 and Prednisolone on Biomarkers in COPD Chronic Obstructive Pulmonary Disease Patients
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Randomised Double-blind Double-dummy Placebo-controlled Five-way Crossover Study to Assess the Effects of Single Oral Doses of SB-681323 75 mg and 25 mg and Prednisolone 10 mg and 30 mg on Biomarkers in Induced Sputum and Blood in COPD Patients
Status:
COMPLETED
Status Verified Date:
2012-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess the effects of single oral doses of SB681323 and prednisolone on biomarkers in induced sputum and blood COPD patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None